A five-point plan against pandemics
Op-ed by Stefan Oschmann, CEO of Merck KGaA, Darmstadt, Germany, and Wolfgang Ischinger, Chairman of the Munich Security Conference, in "EURACTIV" and “Handelsblatt“ from March 30, 2020
Read the full articleCommitted to fight Covid-19
290k
units of interferon beta-1a (Rebif®) donated to the World Health Organization
150k
liters of disinfectants made available to the state of Hesse
Related News
All stories at a glancePress Releases
Merck KGaA, Darmstadt, Germany, Donates two Million N95 Medical Grade Masks
Merck KGaA, Darmstadt, Germany is donating a total of two million N95 medical grade masks in Germany, France, and the United States, among others.
2020/05/12
Press Releases
Merck KGaA, Darmstadt, Germany, is Supporting Darmstadt in the COVID-19 Crisis
Globally, bottlenecks currently exist with respect to the supply of disinfectant and FFP2 masks. Yet hospitals, emergency services and nursing homes in Darmstadt still have a significantly increased need in ...
2020/04/17
Press Releases
Merck KGaA, Darmstadt, Germany Announces its Support of Jenner Institute Reaching ...
Merck KGaA, Darmstadt, Germany and The Jenner Institute today announced that The Jenner Institute has laid the foundation for large-scale production of its Covid-19 vaccine candidate, ChAdOx1 nCoV-19.
2020/04/14
We collaborate with the Bill & Melinda Gates Foundation to fight COVID-19
On March 26, a consortium of healthcare and life sciences companies together with the Bill & Melinda Gates Foundation announced an important collaboration to accelerate the development, manufacture, and delivery of vaccines, diagnostics, and treatments for Covid-19. We are proud to be part of this group. All partners contribute a range of assets, resources, and expertise needed to identify effective and scalable solutions to the pandemic, which is affecting billions worldwide. More information is available here.
Human progress is what we stand for. During these difficult times, we actively contribute resources, full dedication and expertise to fight this COVID-19 pandemic.
Belén Garijo
Member of the Executive Board & CEO Healthcare
A Message from the Executive Board
"All of us at Merck KGaA, Darmstadt, Germany, 57,000 people in 66 countries, are dedicated to serving patients, scientists and customers around the globe."
Read more
Future Insight Prize: Fighting the pandemic
With our support, Pardis Sabeti and James Crowe are working on new diagnostics and treatment options for Covid-19.
Read more
The need to fight Covid-19 is urgent, and open science and trusted data is the path to success. We are calling upon the global scientific community to join us so we can solve these problems as fast as possible. We are going to do all we can to end this pandemic and work towards preventing others in the future. I hope you will join us.
Udit Batra
Member of the Executive Board & CEO Life Science
Expediting Your Covid-19 Response & Vaccine Research
As a global life science tools and equipment supplier, we are here to help in the response to Covid-19. From supplying raw materials and research products for detection and characterization to production, we’ve consolidated relevant product and service offerings within a single page.
Read more
Research Grant for Pandemic Preparedness
The threat from newly emerging viral infections is a global challenge for humanity. We offer research grants for technological solutions towards pandemic preparedness or solutions that could help fighting emerging viral infections.
Read more
How Merck KGaA, Darmstadt, Germany became a manufacturer of disinfectant
Two sites recently demonstrated how the Covid-19 crisis could unlock unimaginable potential and how combining existing competencies and resources made this happen.
Read more
Face shields from a 3D printer
How the Innovation Center team is helping relieve the shortage of personal protective equipment
Read more
Global Health in times of Covid-19
According to the World Health Organization, at least half of the world’s population does not have access to essential health care. In times of Covid-19, the most vulnerable countries will be worst affected.
Read more